Compare Nephrocare Healt with Similar Stocks
Dashboard
The company is Net-Debt Free
Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%
Positive results in Mar 26
With ROE of 13.4, it has a Very Expensive valuation with a 10.7 Price to Book Value
Increasing Participation by Institutional Investors
Stock DNA
Healthcare Services
INR 6,169 Cr (Small Cap)
79.00
63
0.00%
-0.02
11.74%
11.41
Total Returns (Price + Dividend) 
Nephrocare Healt for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Nephrocare Health Services Q4 FY26: Premium Valuation Concerns Overshadow Robust Growth
Nephrocare Health Services Ltd., India's leading dialysis services provider, delivered a strong operational performance in Q4 FY26 with consolidated net profit rising 51.02% year-on-year to ₹30.37 crores, driven by robust revenue expansion and improved operational efficiency. However, the stock faced selling pressure, declining 5.55% to ₹614.35 on May 20, 2026, as investors grappled with stretched valuation multiples that have pushed the company's price-to-earnings ratio to an elevated 79x – significantly above the healthcare services sector average of 63x.
Read full news article Announcements 
Re-Appointment Of Internal Auditor
19-May-2026 | Source : BSEThe Board of Directors at its meeting held on May 19 2026 has re-appointed M/s. BDO India LLP as Internal Auditor as per the disclosure annexed herewith.
Announcement under Regulation 30 (LODR)-Investor Presentation
19-May-2026 | Source : BSEPlease find attached herewith Investor Presentation for quarter and year ended March 31 2026.
Issuance Of Corporate Guarantee
19-May-2026 | Source : BSEThis is to inform you that the Board of Directors in its meeting held on has approved and granted in-principal approval for providing corporate guarantee as per the disclosure annexed herewith.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 7 Schemes (3.17%)
Held by 20 FIIs (9.94%)
Edoras Investment Holdings Pte Ltd (28.3%)
Investcorp India Investments Holding Limited (6.29%)
5.08%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025
Annual Results Snapshot (Standalone) - Mar'26
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






